Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells

K Yacqub‐Usman, MR Pickard, GT Williams - The prostate, 2015 - Wiley Online Library
BACKGROUND New therapies are required for castrate‐resistant prostate cancer (CRPC),
and growth‐arrest specific 5 (GAS5) lncRNA, which riborepresses androgen receptor action …
被引用次数：118 相关文章

Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells

K Yacqub-Usman, MR Pickard… - The Prostate, 2015 - pubmed.ncbi.nlm.nih.gov
Background New therapies are required for castrate-resistant prostate cancer (CRPC), and
growth-arrest specific 5 (GAS5) lncRNA, which riborepresses androgen receptor action, may …

Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.

K Yacqub-Usman, MR Pickard, GT Williams - 2015 - chesterrep.openrepository.com
BACKGROUND: New therapies are required for castrate-resistant prostate cancer (CRPC),
and growth-arrest specific 5 (GAS5) lncRNA, which riborepresses androgen receptor action …

Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.

K Yacqub-Usman, MR Pickard, GT Williams - 2015 - cdr.openrepository.com
BACKGROUND: New therapies are required for castrate-resistant prostate cancer (CRPC),
and growth-arrest specific 5 (GAS5) lncRNA, which riborepresses androgen receptor action …

Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.

K Yacqub-Usman, MR Pickard, GT Williams - The Prostate, 2015 - europepmc.org
Background New therapies are required for castrate-resistant prostate cancer (CRPC), and
growth-arrest specific 5 (GAS5) lncRNA, which riborepresses androgen receptor action, may …

Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells

K Yacqub‐Usman, MR Pickard, GT Williams - The Prostate, 2015 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> BACKGROUND</jats: title>< jats: p> New therapies are required
for castrate‐resistant prostate cancer (CRPC), and growth‐arrest specific 5 (GAS5) lncRNA …
[PDF] core.ac.uk

[PDF][PDF] Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.

K Yacqub-Usman, MR Pickard, GT Williams - core.ac.uk
Levels of GAS5 lncRNA, an apoptosis promoter and riborepressor of the androgen receptor,
are downregulated as prostate cancer cells acquire castrate-resistance, and consequently …